Esophageal Cancer

ASCO GI: Zanidatamab + Chemo Beneficial in HER2-Positive Gastroesophageal Cancer

Physician’s Briefing

ASCO GI: Zanidatamab + Chemo Beneficial in HER2-Positive Gastroesophageal Cancer

12 Jan 2026

2 min read

FDA Approves Imfinzi for Early Gastric and Gastroesophageal Cancers

Physician’s Briefing

FDA Approves Imfinzi for Early Gastric and Gastroesophageal Cancers

03 Dec 2025

2 min read

Physical Activity Levels Linked to Risk for Digestive System Cancers

Physician’s Briefing

Physical Activity Levels Linked to Risk for Digestive System Cancers

05 Nov 2025

2 min read

Read More

Clinical Briefing Report

clinicalbriefingreport.com